Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined

The IPO window remains wide open for biotechs. Two more, Kiniksa Pharmaceuticals and Scholar Rock, make their Wall Street debuts this morning having raised $227 million combined in their IPOs last night.